Kitazawa M, Katagiri T, Suzuki H, Matsunaga S, et al. A 52-week randomized controlled trial of ipragliflozin or sitagliptin in type 2 diabetes combined with metformin: The N-ISM study. Diabetes Obes Metab 2021 Jan 8. doi: 10.1111/dom.14288.
PMID: 33416200